← Leaderboards
Sylvain E. Lesne
University Of Minnesota
$7,997,415
Attributed
$8,762,207
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2008–23$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$8,762,207 · 7
By mechanism
RF1$4,508,502 · 2
R01$3,056,602 · 2
R00$693,236 · 1
R21$422,892 · 1
K99$80,975 · 1
Top collaborators
- Michael K Lee2 shared
Most similar at University Of Minnesota
Same institution · by research overlap
- Dezhi Liao$5,861,824
- Jennifer Nhieu$141,171
- Carol L Cheatham$2,018,240
- Ching Yuan$1,012,410
- Benjamin Hackel$5,467,295
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseasePathologyNeuronsMouse ModelAmyloid Beta-ProteinImpaired CognitionBrainHyperphosphorylated TauTau AggregationNeurofibrillary TanglesSenile PlaquesTau ProteinsMemory ImpairmentReportingTransgenic MiceSynapsesProteinsCognitive DeficitsAlpha SynucleinCognitive FunctionParkinson DiseaseAffectAmyloid
Grant awards (14)
Regulation of human tau expression and tauopathy by alpha-synuclein$764,792
R01 · FY2023 · AG · contact PI
Regulation of human tau expression and tauopathy by alpha-synuclein$764,792
R01 · FY2022 · AG · contact PI
Decision-making alterations in mouse models of Alzheimer's disease$1,818,908
RF1 · FY2021 · AG · contact PI
Alpha-synculein/tau coupling in Alzheimer's disease$422,892
R21 · FY2020 · AG · contact PI
Soluble αSyn is a modulator of AD pathophysiology$2,689,594
RF1 · FY2019 · AG · contact PI
Soluble aSyn is a modulator of AD pathophysiology$307,918
R01 · FY2018 · AG · contact PI
Soluble aSyn is a modulator of AD pathophysiology$307,918
R01 · FY2017 · AG · contact PI
Soluble aSyn is a modulator of AD pathophysiology$307,918
R01 · FY2016 · AG · contact PI
Soluble aSyn is a modulator of AD pathophysiology$306,005
R01 · FY2015 · AG · contact PI
Soluble aSyn is a modulator of AD pathophysiology$297,259
R01 · FY2014 · AG · contact PI
Mechanism of Action of ABeta*56 in Alzheimer's Disease$227,001
R00 · FY2012 · AG · contact PI
Mechanism of Action of ABeta*56 in Alzheimer's Disease$230,717
R00 · FY2011 · AG · contact PI
Mechanism of Action of ABeta*56 in Alzheimer's Disease$235,518
R00 · FY2010 · AG · contact PI
Mechanism of Action of ABeta*56 in Alzheimer's Disease$80,975
K99 · FY2008 · AG · contact PI